Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 466 AL 480

More than Dysbiosis: Imbalance in Humoral and Neuronal Bidirectional Crosstalk Between Gut and Brain in Alzheimer's Disease

Tassibekova G, Zholdassova M, Novosolova N, Malm T, Giniatullin R, Kustubayeva A.

Int J Mol Sci. 2025 Dec 29;27(1):369. doi: 10.3390/ijms27010369.

Dysbiosis and the gut-brain axis impairment in the pathophysiology of Alzheimer's disease and related dementias: is 'pathobiome' an etiological element?

Park G, Chakrabarty P, Efron PA, Nagpal R.

Essays Biochem. 2025 Dec 23;69(6):EBC20253055. doi: 10.1042/EBC20253055.

Neuroinflammatory mechanisms linking high-fat diets to Alzheimer's disease vulnerability: Beyond the amyloid hypothesis

Mackey-Alfonso SE, Barrientos RM.

Alzheimers Dement. 2025 Nov;21(11):e70911. doi: 10.1002/alz.70911.

Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States

Kuhn MK, Proctor EA.

Proteins. 2025 Aug;93(8):1330-1348. doi: 10.1002/prot.26723. Epub 2024 Sep 1.

Active Immunization Targeting Amyloid β for the Treatment of Alzheimer's Disease

Triplett O, Varda N, Decourt B, Vasconcellos R, Sabbagh MN.

Neurodegener Dis. 2025;25(4):202-217. doi: 10.1159/000546287. Epub 2025 May 10.

Dendrimers: Patents for Alzheimer's Disease

Maheshwari S, Singh A.

Recent Pat Nanotechnol. 2025;19(3):356-363. doi: 10.2174/1872210517666230831154408.

Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review

Park JJ, Rim YA, Sohn Y, Nam Y, Ju JH.

Histol Histopathol. 2025 Feb;40(2):157-170. doi: 10.14670/HH-18-766. Epub 2024 May 21.

Microglial purinergic signaling in Alzheimer's disease

Mei SY, Zhang N, Wang MJ, Lv PR, Liu Q.

Purinergic Signal. 2025 Aug;21(4):815-827. doi: 10.1007/s11302-024-10029-8. Epub 2024 Jun 24.

Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease

Shippy DC, Evered AH, Ulland TK.

Immunol Rev. 2025 Jan;329(1):e13365. doi: 10.1111/imr.13365. Epub 2024 Jul 11.

Gut Microbiota Mediates Neuroinflammation in Alzheimer's Disease: Unraveling Key Factors and Mechanistic Insights

Junyi L, Yueyang W, Bin L, Xiaohong D, Wenhui C, Ning Z, Hong Z.

Mol Neurobiol. 2025 Mar;62(3):3746-3763. doi: 10.1007/s12035-024-04513-w. Epub 2024 Sep 25.

Advanced nano delivery system for stem cell therapy for Alzheimer's disease

Pan Y, Li L, Cao N, Liao J, Chen H, Zhang M.

Biomaterials. 2025 Mar;314:122852. doi: 10.1016/j.biomaterials.2024.122852. Epub 2024 Sep 30.

Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions

Almutary AG, Begum MY, Kyada AK, Gupta S, Jyothi SR, Chaudhary K, Sharma S, Sinha A, Abomughaid MM, Imran M, Lakhanpal S, Babalghith AO, Abu-Seer EA, Avinash D, Alzahrani HA, Alhindi AA, Iqbal D, Kumar S, Jha NK, Alghamdi S.

Ageing Res Rev. 2025 Feb;104:102548. doi: 10.1016/j.arr.2024.102548. Epub 2024 Oct 16.

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease

Karati D, Meur S, Roy S, Mukherjee S, Debnath B, Jha SK, Sarkar BK, Naskar S, Ghosh P.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2319-2342. doi: 10.1007/s00210-024-03500-1. Epub 2024 Oct 21.

Novel Emerging Targets Identification in Reducing Risk of Alzheimer's Disease

Sharma S, Rahate K, Kumar R.

Cent Nerv Syst Agents Med Chem. 2025;25(4):454-474. doi: 10.2174/0118715249333381241012073557.

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer's Pathogenesis

Almeida ZL, Vaz DC, Brito RMM.

Mol Neurobiol. 2025 Apr;62(4):4391-4419. doi: 10.1007/s12035-024-04543-4. Epub 2024 Oct 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias